Josef S Smolen

Research interests

Publications

• EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

  Annals of the Rheumatic Diseases · 2023 · https://doi.org/10.1136/ard-2023-224762

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/ard-2022-223356

• 2021 DORIS definition of remission in SLE: final recommendations from an international task force

  Lupus Science & Medicine · 2021 · https://doi.org/10.1136/lupus-2021-000538

• EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-217159

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2019-216655

• 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-216924

• 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

  Arthritis & Rheumatology · 2019 · https://doi.org/10.1002/art.40930

• 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215089

• 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2018-214819

• Rheumatoid arthritis

  Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/nrdp.2018.1

• Diagnosis and Management of Rheumatoid Arthritis

  JAMA · 2018 · https://doi.org/10.1001/jama.2018.13103

• 2016 update of the EULAR recommendations for the management of early arthritis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2016-210602

• Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211734

• European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

  Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-208337

• A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209519

• Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

  Annals of the Rheumatic Diseases · 2015 · https://doi.org/10.1136/annrheumdis-2015-207524

• A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2014-205207

• Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-205139

• Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

  Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2012-202469

• 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

  Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27584

• EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2010.130476

• 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2010.138461

• European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

  Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2009.117200

• Dickkopf-1 is a master regulator of joint remodeling

  Nature Medicine · 2007 · https://doi.org/10.1038/nm1538

• EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

  Annals of the Rheumatic Diseases · 2007 · 10.1136/ard.2007.070367

• Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus: An open‐label study

  Arthritis & Rheumatism · 2004 · https://doi.org/10.1002/art.20576

• A simplified disease activity index for rheumatoid arthritis for use in clinical practice

  Lara D. Veeken · 2003 · 10.1093/rheumatology/keg072

• Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: A randomized controlled trial

  Arthritis Care & Research · 2002 · https://doi.org/10.1002/art1.10246

• Serum interleukin‐15 is elevated in systemic lupus erythematosus

  Lara D. Veeken · 2001 · https://doi.org/10.1093/rheumatology/40.8.876

• Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

  New England Journal of Medicine · 2000 · https://doi.org/10.1056/nejm200011303432202

• Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme

  Lara D. Veeken · 1998 · https://doi.org/10.1093/rheumatology/37.2.196

• Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community

  Arthritis & Rheumatism · 1993 · 10.1002/art.1780360309

Current projects

No projects listed.